PUM1

Pumilio homolog 1 · Q14671 · PUM1 on Sugi Atlas →

0 patent compounds predicted against PUM1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PUM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Role of Specific microRNAs in Cluster Headache nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
H19 in Acute Lymphoblastic Leukemia. nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression nanUNKNOWN
miRNA as a Growth Plate Marker After GH nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis nanUNKNOWN
Collection of Blood Samples for DNA in Motor Neuron Disease nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate Cancer nanUNKNOWN
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Timisnar - Biomarkers Substudy (Timisnar-mirna) nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PUM1 binder may also engage these)

ProteinNameSimilarity
Q80U78 1.000 Q80U78 →
Q5R5X3 1.000 Q5R5X3 →
Q66KI6 1.000 Q66KI6 →
PUM2 Pumilio homolog 2 1.000 landscape →
Q2VB19 1.000 Q2VB19 →
E3WDQ9 0.998 E3WDQ9 →
Q80U58 0.997 Q80U58 →
P40645 0.991 P40645 →
Q9ZW06 0.991 Q9ZW06 →
Q5RCU4 0.990 Q5RCU4 →
P0CG40 0.989 P0CG40 →
F1M8W4 0.989 F1M8W4 →
P35710 0.989 P35710 →
Q64HY3 0.988 Q64HY3 →
Q52JK6 0.988 Q52JK6 →
Q9WVH4 0.988 Q9WVH4 →
Q6EUW1 0.988 Q6EUW1 →
Q4VYR7 0.988 Q4VYR7 →
FOXO3 Forkhead box protein O3 0.988 landscape →
Q05201 0.988 Q05201 →
PAX2 Paired box protein Pax-2 0.988 landscape →
Q7TN98 0.988 Q7TN98 →
Q9Z191 0.988 Q9Z191 →
A1C602 0.988 A1C602 →
P16376 0.987 P16376 →
O95677 0.987 O95677 →
A0A0G2JTZ2 0.987 A0A0G2JTZ2 →
Q7RUA4 0.987 Q7RUA4 →
Q6EUW2 0.987 Q6EUW2 →
Q18955 0.987 Q18955 →